Rodríguez-Morales AJ, Rodríguez CN, Garcia A, Pastran B, Jiménez I, Meijomil P

Idioma: Ingles.
Referencias bibliográficas: 17
Paginas: 115-118
Archivo PDF: 81.76 Kb.

RESUMEN

En el presente estudio se realiza una evaluación de la actividad antimicrobiana de ciertas drogas contra cepas de Streptococcus agalactiae aisladas de infecciones en un hospital general de Caracas, Venezuela, en el período 1997-2003. S. agalactiae mostró 18,8% de resistencia a clindamicina, 16,4% a ciprofloxacina, 9,8% a eritromicina. Para penicilina la sensibilidad fue de 98.9%. No se observó resistencia a teicoplanina o a vancomicina (100% sensible).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Azavedo, J. C., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504–3508.

2. Bland, M. L., S. T. Vermillion, D. E. Soper, and M. Austin. 2001. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am. J. Obstet. Gynecol. 184:1125–1126.

3. De Mouy, D., J. D. Cavallo, R. Leclercq, R. Fabre, and AFORCORPI-BIO Network. 2001. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob. Agents Chemother. 45:2400–2402.

4. Fernandez, M., M. E. Hickman, and C. J. Baker. 1998. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42:1517–1519.

5. Werno, A.M., Anderson, T.P., and D. R. Murdoch. 2003. Antimicrobial susceptibilities of group B streptococci in New Zealand. Antimicrob. Agents Chemother. 47:2710–2711.

6. Hsueh, P. R., L. J. Teng, L. N. Lee, S. W. Ho, P. C. Yang, and K. T. Luh. 2001. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45:3205–3208.

7. Lin, F.-Y. C., P. H. Azimi, L. E. Weisman, J. B. Philips, J. Regan, P. Clark, G. G. Rhoads, J. Clemens, J. Troendle, E. Pratt, R. A. Brenner, and V. Gill. 2000. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995–1998. Clin. Infect. Dis. 31:76–79.

8. Morales, W. J., S. S. Dickey, P. Bornick, and D. V. Lim. 1999. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am. J. Obstet. Gynecol. 181:310–314.

9. Murdoch, D. R., and L. B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother. 45:3623–3624.

10. Pearlman, M. D., C. L. Pierson, and R. G. Faix. 1998. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet. Gynecol. 92:258–261.

11. Rouse, D. J., W. W. Andrews, F.-Y. C. Lin, C. W. Mott, J. C. Ware, and J. B. Philips. 1998. Antibiotic susceptibility profile of group B Streptococcus acquired vertically. Obstet. Gynecol. 92:931–934.

12. Grimwood, K., P. R. Stone, I. A. Gosling, R. Green, B. A. Darlow, D. R. Lennon, and D. R. Martin. 2002. Late antenatal carriage of group B Streptococcus by New Zealand women. Aust. N. Z. J. Obstet. Gynecol. 42:182–186.

13. Stylianopoulos, A., N. Kelly, and S. Garland. 2002. Is penicillin and/or erythromycin resistance present in clinical isolates of group B Streptococcus in our community? Aust. N. Z. J. Obstet. Gynecol. 42:543–544.

14. Perez, J., Limansky, A., Toresani, I., Ebner, G., Di Bartolomeo, S., de Inocenti, I., Pretto, G., Salazar, N., Laferrara, M., Bottiglieri, M., Ballester, D., Morales, M., Rivera, L., Cacace, M.L., Castro, H., Roldan, L., Notario, R., Borda, N., Cera, G., Spoletti, M.J., Gregorini, E., and E. G. Sutich. 2004. Distribución de tipos capsulares y sensibilidad antimicrobiana de Streptococcus agalactiae causando infecciones en Argentina. Rev. Argent. Microbiol. 36:63-67.

15. Riera, L., Benavides, G., and N. Morillo. 1993. Colonización por Streptococcus grupo B en embarazadas y recién nacidos en una comunidad de Venezuela. Enferm. Infecc. Microbiol. Clin. 11:295-8.

16. National Committee for Clinical Laboratory Standards. 2002. Performance Standards for Antimicrobial Susceptibility Testing; approved standard, 8th ed. NCCLS document M2-A6 and M7A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.

17. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482–492.